Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples